American CryoStem to Participate in World Medical Tourism & Global Healthcare Congress

ACCESSWIRE

Mon, Sep 26, 2016, 7:00 AM

EATONTOWN, NJ / ACCESSWIRE / September 26, 2016 / American CryoStem Corporation (CRYO), a leading developer, marketer and licensor of patented adipose tissue based cellular technologies for the regenerative and personalized medicine industries with laboratories in New Jersey, and licensed labs in Tokyo, Hong Kong and Shenzhen, China, today announced that John Arnone, CEO of CRYO will moderate The World Medical Tourism & Global Healthcare Congress Stem Cell Panel and will also be presenting the Company's adipose derived stem cell products and services at the Educational Breakout Session titled "Science Fiction to Science Fact: Get to Know Stem Cells as the Future of Medicine". The World Medical Tourism & Global Healthcare Congress is being held at the Gaylord National Resort & Convention Center in Washington DC on September 25th-28th, 2016.

The Medical Tourism & Global Healthcare Congress (WMTC) is the most comprehensive international healthcare conference and medical tourism tradeshow in the industry. WMTC is the only global event where organizations can connect with leaders from healthcare, insurance, government, and industry from nearly 100 countries.

"We are pleased to be invited to lead the stem cell panel discussion at the 9th annual meeting" stated John Arnone, CEO of American CryoStem Corporation. "This venue creates a global networking opportunity for companies to build international business relationships and exchange information about medical products and services and the latest trends in the global Regenerative Medicine industry."

About American CryoStem Corporation:

American CryoStem Corporation (OTC Pink: CRYO), Founded in 2008, is a leading developer, manufacturer, and marketer of life-enhancing, stem cell technologies in the field of Personalized, Regenerative Medicine. The company offers researchers, physicians and patients a proprietary stem-cell collection, processing and cryogenic storage platform to prepare patients for (current or future) regenerative applications using their own adult stem cells to address the impact of aging, injury and other medical disorders. Adipose derived stem cells use in Regenerative Medicine has many applications, the pure fat tissue may be used as a natural-cosmetic filler to restore a younger appearance, or the cells may be used to address the wear and tear of joints and in other degenerative diseases especially where a family history of illness is known.

For more information please visit: www.americancryostem.com

SOURCE: American CryoStem Corporation

Berkshire's profit plunges 64% on portfolio holdings as Buffett sells Apple
Berkshire Hathaway's first quarter profits plummeted along with the paper value of its investments, but the company said Saturday that most of the businesses it owns outright performed well. The figures were heavily influenced by a large drop in the paper value of Berkshire’s investments. Buffett encourages investors to pay more attention to the conglomerate’s operating earnings that exclude the investment figures.
Associated Press Finance
This Dividend Stock Yields 4.4% and Has 15 Consecutive Years of Dividend Increases. Here's Why It's a Buy Now
This industry-leading company is out of favor and worth buying now.
Motley Fool
Here's the 1 Stock Warren Buffett Thinks Should Outperform the S&P 500 Without as Much Downside
A big cash pile protects the above-average core operations of this stellar company.
Motley Fool
U.S. Money Supply Is Doing Something So Rare That It Hasn't Happened Since the Great Depression -- and a Big Move in Stocks May Follow
M2 money supply hasn't done this in nine decades.
Motley Fool
Berkshire shareholders reject climate, diversity, China proposals
Berkshire Hathaway Inc shareholders on Saturday overwhelmingly rejected six proposals addressing environmental and social policy issues at Warren Buffett's conglomerate, all of which the billionaire investor and his board opposed. By margins of more than 4-to-1, shareholders at Berkshire's annual meeting voted against two proposals that the company's insurance and energy operations disclose more about their efforts to address climate change including greenhouse gas emissions. They also turned down a proposal for more disclosure about efforts to promote diversity, equity and inclusion in the workplace.
Reuters
Warren Buffett says Berkshire sold entire Paramount stake at a loss
NEW YORK (Reuters) -Warren Buffett said on Saturday that Berkshire Hathaway sold its entire holding in media and entertainment company Paramount Global at a loss and he took sole responsibility for the decision. "It was 100% my decision, and we've sold it all, and we lost quite a bit of money," Buffett said at Berkshire's annual shareholder meeting in Omaha, Nebraska. Berkshire held 63.3 million Paramount Class B shares at the end of 2023 or about 10.1% of the company.
Reuters
Move Over, Nvidia: Billionaire Dan Loeb Is Betting on This Dividend-Paying Magnificent Seven Stock to Win the Artificial Intelligence (AI) Race Instead
Dan Loeb bet on one of the cheaper Magnificent Seven stocks as an underrated AI play.
Motley Fool
Trump Media stock tumbles as the SEC charges its auditor with 'massive fraud'
Trump Media's auditor was a "sham" and committed "massive fraud" for over two years, regulators said.
Business Insider
Should I Take a $48,000 Lump Sum or $462 Annuity From My Pension?
Buyout decisions have become increasingly common for those with a pension plan. If you get this offer, the most important questions to deal with include when you would you receive the payout, and how long you expect to live. The earlier you would receive a lump sum payout, the more it will be worth to you […] The post Should I Take a $48,000 Lump Sum or $462 Monthly Payments for a Pension Annuity? appeared first on SmartReads by SmartAsset.
SmartAsset
This Billionaire Is Selling This Magnificent Dividend Stock: Here Are 3 Other Higher-Yielding Dividend Stocks He Likes Instead
Bill Gross thinks a few other MLPs are more attractive than Enterprise Products Partners right now.
Motley Fool

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

American CryoStem to Participate in World Medical Tourism & Global Healthcare Congress

Recommended Stories

Berkshire's profit plunges 64% on portfolio holdings as Buffett sells Apple

This Dividend Stock Yields 4.4% and Has 15 Consecutive Years of Dividend Increases. Here's Why It's a Buy Now

Here's the 1 Stock Warren Buffett Thinks Should Outperform the S&P 500 Without as Much Downside

U.S. Money Supply Is Doing Something So Rare That It Hasn't Happened Since the Great Depression -- and a Big Move in Stocks May Follow

Berkshire shareholders reject climate, diversity, China proposals

Warren Buffett says Berkshire sold entire Paramount stake at a loss

Move Over, Nvidia: Billionaire Dan Loeb Is Betting on This Dividend-Paying Magnificent Seven Stock to Win the Artificial Intelligence (AI) Race Instead

Trump Media stock tumbles as the SEC charges its auditor with 'massive fraud'

Should I Take a $48,000 Lump Sum or $462 Annuity From My Pension?

This Billionaire Is Selling This Magnificent Dividend Stock: Here Are 3 Other Higher-Yielding Dividend Stocks He Likes Instead